How much is an Orthopedic Surgeon worth to a hospital? Answer: $2.7M
How much is a physician worth to a hospital? About $1.4M (Dallas Business Journal) Irving-based Merritt Hawkins’ new 2013 Survey of […]
Ouch! Former Integra LifeSciences employees admit to hospital fraud scheme
Former Integra sales rep, manager admit to $800k hospital fraud scheme (OrthoSpineNews) Filings: USA versus Daniel Metz USA versus Charles Carey
Spotlight on Titan Spine, an emerging growth Spinal Fusion company
Room to Grow: Emerging Growth Orthopedic Companies (ODTMag) This is the fifth year, as part of our Top Company Report
Spotlight on IlluminOss, an emerging small bones fracture repair company
Room to Grow: Emerging Growth Orthopedic Companies (ODTMag) This is the fifth year, as part of our Top Company Report
Spotlight on Benvenue Medical, an emerging growth Spine company
Room to Grow: Emerging Growth Orthopedic Companies (ODTMag) This is the fifth year, as part of our Top Company Report
Spotlight on ConforMIS, an emerging growth Joint Replacement company
Room to Grow: Emerging Growth Orthopedic Companies (ODTMag) This is the fifth year, as part of our Top Company Report
Symmetry Surgical sold to Tecomet for $450M
List of all Mergers and Acquisitions SYMMETRY MEDICAL SELLING OEM SOLUTIONS (Orthopedics This Week) Symmetry Medical Inc. will be selling its
UPDATE: Zimmer sues Stryker for Trojan Horse scheme to steal its customers
UPDATE… Most Of ZMH / SYK Sales Trade Secrets Suit Survives Law360, Los Angeles (August 06, 2014, 7:02 PM ET) —
Commentary: When to operate on a torn ACL?
To Operate or Not to Operate? That Is (Still) the Question (JBJS) Commentary on an article by Hege Grindem, PT, PhD,
Smith & Nephew will cut implant prices in half with the “no rep” option
Read the list… 14 Low Cost Implant Companies SMITH & NEPHEW GOES REP-LESS WITH SOME HIPS AND KNEES (Orthopedics This Week)
Trend: Chinese hip and knee patients are getting younger
Average age of degenerative joint disease patients declines (China Post) The average age of degenerative joint disease patients has been dropping
JBJS asks: Are we over-treating Clavicular Fractures?
EDITOR’S CHOICE: Are We Overtreating Clavicular Fractures? (JBJS) This is my first Editor’s Choice for OrthoBuzz as new Editor-in-Chief of JBJS. I
Faster recovery and less pain in Knee Revisions with the use of a trabecular metal cone
Faster Recovery, Less Pain in Knee Revision (Orthopedics This Week) AAOS news New technique promising to treat revision TKR bone loss
The bone and joint regenerative medicine market will double in 7 years
REGENERATIVE MEDICINE MARKET ON GROWTH SPURT (Orthopedics This Week) According to a new market research report published by Transparency Market Research, the
Three guys and a better pedicle drill
THREE GUYS AND A BETTER PEDICLE DRILL (Orthopedics This Week) Garages and basements are iconic and sacred spaces in the history
Smith & Nephew CEO talks to being a large acquisiton target
Smith & Nephew sees more sector deals, not under investor pressure (Reuters) CEO sees continuing tax-driven inversion deals in sector Low-cost
Infuse bone graft lawsuits are piling up on Medtronic
Medtronic Infuse—Another Bone of Contention (Lawyers and Settlements) Another Medtronic Infuse bone graft lawsuit has been filed against the company, again for providing
First-half 2014 medtech acquisition values surpasses 2013 in total
First-half medtech acquisition value surpasses 2013 total (EP Vantage) Source EP Vantage Company Thermo Fisher Scientific, Abbott Laboratories, Ansell, Bausch + Lomb, Baxter International, Bayer, bioMérieux, Cardinal
Wow! The IRS has collected $1.4B in medtech excise tax payments in 2013
Exclusive: IRS collected $1.4B in medtech excise tax payments in 2013 (MassDevice) The IRS calculates that medtech companies paid the federal
DePuy-Synthes eliminates all non-sales travel in a bold cost-cutting measure
DEPUY SYNTHES CONTINUES COST-CUTTING (Orthopedics This week) DePuy Synthes continues its cost-cutting measures. According to a July 17, 2014, Wall Street Journal
Wright Medical and Tornier are left patiently looking for an acquirer
Wright Medical And Tornier See A Desirable Partner Choose Another (Seeking Alpha) Summary Stryker was expected to be a buyer in
Medtronic taking advantage of 175 iOS apps so that mobile sales/marketing employees can work more effectively
Apple: Medtronic has developed 175 iPhone and iPad apps for employees to use (MedCityNews) When I tuned into Apple’s quarterly earning conference
Analysis of FDA’s new 510(k) guidance by the Emergo Group
US FDA publishes insight into 510(k) Substantial Equivalence determination process (MassDevice) New draft guidance from the US Food and Drug Administration
Biotech funding is on the rise and Biotech IPOs are healthy
Venture-backed healthcare deals rise to $2.7B in Q2 (MedCityNews) About $13.88 billion in venture capital backed 974 deals in the second
Stryker sells Bone Morphogenetic Protein assets (BMP-7) to a pharma company
Mariel Therapeutics to Acquire Stryker’s BMP-7 Assets (HealthPointCapital) The biopharmaceutical company, Mariel Therapeutics, entered into a definitive agreement to acquire Stryker’s Bone Morphogenetic Protein-7
European Commission stops review of Zimmer-Biomet merger
European Commission Halts Review Of Zimmer’s Biomet Bid (MedDeviceOnline) Your Dashboard for the Zimmer-Biomet Merger The European Commission said it is
Zimmer recalls over 40,000 NexGen Total Knee Replacements
Your Dashboard for the Zimmer-Biomet Merger OVER 40,000 ZIMMER NEXGEN KNEE TIBIAL COMPONENTS RECALLED (Orthopedics This Week) Zimmer Holdings, Inc. is
Intuitive Surgical Executive explains why Robotic Surgery Is useful
Intuitive Surgical Exec: Here Is Why Robotic Surgery Is Useful (Forbes) Intuitive Surgical is the maker of the Da Vinci Surgical System,
The case for the image-to-implant ConforMIS Total Knee
Image-to-Implant Production Offers Advantages in Knee Replacement (Orthopreneur) While many medical devices lend themselves to a “one size fits all” production
Data says – Surgeons who perform more hip surgeries have fewer complications
Success With Total Hip Replacements Is All About the Numbers (Arthritis Today) Surgeons who perform more hip surgeries per year have
Is the Orthopedics Market Slowing Down?
Is This Huge Market Slowing Down? (Fool.com) Waiting for a recovery in the orthopedic market isn’t exactly waiting for Godot, but
Orthopedists earn the most of any specialty (infographic)
Here’s How Much Money Doctors Actually Make (Medscape) Medscape, a subsidiary of the medical information website WebMD, has released its 2014 Physician
Surgeons describe the purpose for misunderstood knee ligament
Surgeons describe new ligament in the human knee (ScienceDaily) SUMMARY: Two knee surgeons in Belgium have provided the first full anatomical
Biomet CEO makes the case that Joint Replacements lower overall healthcare costs
JOINT-REPLACEMENT DEVICES A SOCIETAL BARGAIN (Orthopedics This Week) We read a lot about the costs of medical technology to patient care
How Hospitals drive down the true cost of total knee replacements
Total knee replacements: A race to the bottom (KevinMD) A total knee replacement is a very common operation and more than 700,000
NuVasive opens new international operations center in Ireland
Med-tech player NuVasive sets up in Waterford with 30 high-skill jobs (Silicone Republic) Medical-device company NuVasive Inc is establishing an international
SEC subpoenas Biomet regarding operations in Brazil and Mexico
SEC Subpoenas Biomet for Potential FCPA Violations (Compliance Week) SEC Filing BioMet said in a filing with the Securities and Exchange Commission last
Israeli startup improves coatings for total joints
FIRM OFFERS NEW COATING FOR THR (Orthopedics This Week) An Israeli company is tackling a long-term problem faced by patients who
Cellular Biomedical Group increases knee cartilage in some Chinese patients
CHINA TESTS REPORT CARTILAGE REGROWTH (Orthopedics This Week) A clinical trial of human adipose-derived mesenchymal cell (haMPC) therapy for knee osteoarthritis
Zimmer may have to sell off some joint replacement businesses to pass Hart-Scott-Rodino Antitrust test and gain FTC approval
FTC SENDS “SECOND REQUEST” TO ZIMMER/BIOMET (Orthopedics This Week) Your Dashboard for Zimmer-Biomet The Federal Trade Commission (FTC) has sent Zimmer
Commentary on the recent M&A movements in Orthopedics
Tides Turn for These Orthopedic Firms (MorningStar) With the announcement that Zimmer (ZMH) plans to acquire Biomet, the competitive dynamics in the orthopedic implant
Arthrodesis is better than revision after failed Total Ankle Replacement
Arthrodesis may be better indicated after failed TAR than re-arthroplastyArthrodesis may be better indicated after failed TAR than re-arthroplasty (Healio) With
Stem Cell therapy is going to the dogs
STEM CELLS GOING TO THE DOGS (Orthopedics This Week) Aratana Therapeutics, Inc. has entered into an agreement to develop and commercialize
Olympus Biotech puts a fork into its efforts to commercialize OP-1
OLYMPUS HALTS OP-1 EFFORT (Orthopedics This Week) Olympus Biotech Corporation has put a fork into its efforts to commercialize OP-1. After
Stryker acquires Small Bone Innovations for $375M (7.8 X sales last 12 months)
Anthony G. Viscogliosi Comments on Stryker Acquisition of Small Bone Innovations, Inc. (press release) Small Bone Innovations, Inc. (SBi) today announced
Trend continues as Big Orthos focus on emerging markets
Emerging Markets Heat Up for Device Makers (Motley Fool) Want a deeper analysis? With the medical device industry struggling for growth, leading
Researchers find biomarker that predicts OsteoArthritis
BIOMARKERS MAY PREDICT OSTEOARTHRITIS (Orthopedics This Week) Researchers have found a correlation between the presence of biomarkers in the blood, known
Growing trend in Sports Medicine, the “Tommy John” surgery for pitchers
Tommy John Surgery, a Rising Epidemic? (Athletico) If you follow professional baseball, I am sure you have observed an alarming rate
Get on FDA’S Cloud
GET ON FDA’S CLOUD (Orthopedics This Week) The FDA’s collective heads are in the clouds when it comes to “Big Data.”
FDA issues two draft guidances on Social Media
Double Trouble: Two New FDA Draft Guidances on Social Media (OrthoSpineNews) Two NEW FDA DRAFT Guidances On the Use of Social